Brevetti EPO No.4048260 2026.03.11
Brevetti EPO
(10) Registration Number and Date
2026000194 2026.04.23
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2026/000194 2020.10.20
(40) Publication Number and Date
SM /T/2026/000194 2026.04.23
(30) Priority Details
US 201962923945 P
2019.10.21
(71/73) Applicant
(72) Inventor
(IT) PIERCEALL, William Edward : Celgene Summit West556 Morris Avenue, Summit, NJ 07901, US
(IT) MOHAN, Adithi : c/o Celgene Corporation 1500 Owens Street, Suite 600, San Francisco, CA 94185, US
(IT) CHANG, Henry : c/o Celgene Corporation 1500 Owens Street, Suite 600, San Francisco, CA 94185, US
(IT) FILVAROFF, Ellen : c/o Celgene Corporation 1500 Owens Street, Suite 600, San Francisco, CA 94185, US
(74) Representative Name
(IT) DE BENEDETTI, Jacopo : Via L. Cibrario, 25, 47893 Borgo Maggiore RSM , SM
(54) Title
(IT) COMBINAZIONE DI COMPOSTI DI 4-AMMINOISOINDOLIN-1,3-DIONE SOSTITUITI E DI SECONDI AGENTI ATTIVI PER L'USO NEL TRATTAMENTO DI UNA CONDIZIONE MALIGNA EMATOLOGICA
(EN) COMBINATION OF SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS AND SECOND ACTIVE AGENTS FOR USE IN TREATING A HEMATOLOGICAL MALIGNANCY
(57) Abstract
(58) Citations